Envoy Medical announces three patents for implantable cochlear systems

Envoy Medical recently has been awarded three additional patents. These patents are further evidence of Envoy Medical’s determination to be an innovation leader in hearing health to benefit patients with significant hearing loss. The patents are as follows: The US Patent & Trademark Office issued Envoy Medical Corporation US Pat. No. 11,839,765 on December 12, 2023. The title of the patent is Cochlear Implant System with Integrated Signal Analysis Functionality. The US Patent & Trademark Office issued Envoy Medical Corporation US Pat. No. 11,865,339 on January 9, 2024. The title is Cochlear Implant System with Electrode Impedance Diagnostics. The European Patent Office granted European Pat. No. 3927420 on January 10, 2024. The title is Implantable Cochlear System with Integrated Components and Lead Characterization.